Form 4: Director Carrie Cox Receives Solventum RSU Grant

Solventum Corp director Carrie S. Cox was granted 4,848 restricted stock units as part of standard equity compensation.

Summary

• Director Carrie S. Cox acquired 4,848 Restricted Stock Units (RSUs) on May 15, 2026.
• Each RSU represents a contingent right to receive one share of Solventum Corp common stock.
• The grant is subject to a vesting schedule requiring continued service through May 15, 2027.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations or financial outlook.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

• None identified.

Risks

• Vesting is contingent upon continued service, creating potential for forfeiture if the director leaves the board before May 15, 2027.

Future Outlook

The RSUs are scheduled to fully vest on May 15, 2027, provided the director remains in service.

Industry Context

StockSavvy.ai notes that equity grants to board members are standard corporate governance practices designed to incentivize long-term oversight and alignment with shareholder interests.

Comparison to Industry Standards

• The grant of RSUs to non-employee directors is consistent with standard compensation practices for publicly traded companies in the healthcare and technology sectors.

Stakeholder Impact

• Minimal impact on shareholders as this represents standard director compensation.

Next Steps

• Vesting of the 4,848 RSUs on May 15, 2027.

Key Dates

Keywords

Solventum, SOLV, Form 4, Insider Trading, Equity Compensation, Director Compensation